ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY REDUCES HBsAg LEVELS IN HBeAg-NEGATIVE, GENOTYPE D CHRONIC HEPATITIS B PATIENTS FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUE TREATMENT: THE HERMES STUDY

被引：6
|
作者：
Lampertico, P. [1 ]
Brunetto, M. R. [2 ]
Craxi, A. [3 ]
Gaeta, G. B. [4 ]
Rizzetto, M. [5 ]
Palmieri, G. [6 ]
Colombo, M. [1 ]
机构：
[1] Univ Milan, Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[2] Univ Hosp Pisa, Liver Unit, Reference Ctr Chron Liver Dis & HCC Tuscany Reg, Pisa, Italy
[3] Univ Palermo, DiBiMIS, Gastroenterol & Hepatol, Palermo, Italy
[4] Univ Naples 2, Sect Infect Dis & Viral Hepatitis, Dept Internal Med, Naples, Italy
[5] Univ Turin, Dept Gastroenterol, Turin, Italy
[6] Roche, Monza, Italy
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30179-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LP25
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 50 条
  • [31] BASELINE HBSAG LEVELS PREDICT HBSAG LOSS IN HBEAG NEGATIVE BUT NOT IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEGASYS®) AND ADEFOVIR (HEPSERA): AN INTERIM ANALYSIS
    Takkenberg, Bart
    Zaaijer, Hans L.
    de Niet, Annikki
    Weegink, Christine J.
    Terpstra, Valeska
    Koot, Maarten
    Dijkgraaf, Marcel
    Jansen, Peter L.
    Janssen, Harry L.
    Beld, Marcel
    Reesink, Hendrik W.
    HEPATOLOGY, 2009, 50 (04) : 536A - 537A
  • [32] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [33] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    Hepatology International, 2008, 2 : 102 - 110
  • [34] A real-world experience in baseline predictors of virological response to Peginterferon Alfa-2a in patients with HBeAg-negative chronic hepatitis B
    Chen, Yi-Cheng
    Jeng, Rachel Wen-Juei
    Hsu, Chao-Wei
    Lin, Chun-Yen
    Sheen, I-Shyan
    Chien, Rong-Nan
    Liaw, Yun-Fan
    HEPATOLOGY, 2016, 64 : 927A - 927A
  • [35] PEGBELIVER STUDY: HBSAG DECLINE AT WEEK 24 OF EXTENDED PEGINTERFERON ALFA-2A (PEG-IFNα-2A) THERAPY IS SIGNIFICANTLY ASSOCIATED WITH POST-TREATMENT RESPONSE IN HBEAG-NEGATIVE GENOTYPE D PATIENTS
    Lampertico, P.
    Vigano, M.
    Lanza, A. Galeota
    Sagnelli, E.
    Fasano, M.
    Di Marco, V.
    Bininsegna, S.
    Farci, P.
    Fargion, S.
    Giuberti, T.
    Iannacone, C.
    Massetto, B.
    Martins, E. B.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S293 - S293
  • [36] INTRAHEPATIC HBSAG PREDICTS TREATMENT RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR; AN INTERIM ANALYSIS
    Takkenberg, B.
    De Niet, A.
    Terpstra, V.
    Zaaijer, H.
    Weegink, C.
    Koot, M.
    Dijkgraaf, M.
    Jansen, P.
    Beld, M.
    Reesink, H.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S397 - S397
  • [37] CHANGES OF SERUM HBSAG LEVELS IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS UNDER LONG-TERM THERAPY WITH NUCLEOS(T)IDE ANALOGUE(S)
    Papatheodordis, George V.
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Margariti, Ekaterini
    Exarchos, Xenofon
    Kokkonis, George
    Papaioannou, Christos
    Akriviasdis, Evangelos A.
    Manesis, Emanuel K.
    HEPATOLOGY, 2011, 54 : 1054A - 1054A
  • [38] ADDITION OF PEGINTERFERON ALFA-2a INCREASES HBsAg DECLINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY: RESULTS FROM A MULTICENTER RANDOMIZED CONTROLLED TRIAL. (PAS STUDY)
    Farag, Mina S.
    Fung, Scott K.
    Van Campenhout, Margo
    Van Erpecum, Karel J.
    Wong, David K. H.
    Boonstra, Andre
    Verhey, Elke
    De Man, Robert A.
    Liem, Kin Seng
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2019, 70 : 127A - 128A
  • [39] EARLY ON-TREATMENT HBSAG AND HBV DNA LEVELS IDENTIFY HBEAG-NEGATIVE PATIENTS NOT RESPONDING TO 48 OR 96 WEEKS OF PEGINTERFERON ALFA-2A THERAPY
    Rijckborst, Vincent
    Hansen, Bettina E.
    Ferenci, Peter
    Brunetto, Maurizio R.
    Tabak, Fehmi
    Cakaloglu, Yilmaz
    Lanza, Alfonso G.
    Messina, Vincenzo
    Iannacone, Claudio
    Massetto, Benedetto
    Martins, Eduardo B.
    Colombo, Massimo
    Janssen, Harry L.
    Lampertico, Pietro
    HEPATOLOGY, 2010, 52 (04) : 557A - 558A
  • [40] HBsAg clearance in chronic hepatitis B patients with add-on pegylated interferon alfa-2a to ongoing tenofovir treatment: A randomized controlled study
    Al Ashgar, Hamad
    Peedikayil, Musthafa C.
    Al Quaiz, Mohammed
    Al Sohaibani, Fahad
    Al Fadda, Abdulrahman
    Khan, Mohammed Q.
    Thoralsson, Einar
    Al Thawadi, Sahar
    Al Jedai, Ahmed
    Al Kahtani, Khalid
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2017, 23 (03): : 190 - 198
12345